Narayanan; Ramesh

Patent Applications and Registrations

Patent applications and USPTO patent grants for Narayanan; Ramesh.The latest application filed is for "selective androgen receptor degrader (sard) ligands and methods of use thereof".

Company Profile

22.38.49

Narayanan; Ramesh - Cordova TN
NARAYANAN; Ramesh - Tuscaloosa AL
Narayanan; Ramesh - Cordove TN
Narayanan; Ramesh - Novi MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20220081401 - Narayanan; Ramesh ; et al.	2022-03-17
Selective androgen receptor degrader (SARD) ligands and methods of use thereof Grant 11,273,147 - Narayanan , et al. March 15, 2	2022-03-15
Selective androgen receptor degrader (SARD) ligands and methods of use thereof Grant 11,230,523 - Narayanan , et al. January 25, 2	2022-01-25
Selective androgen receptor degrader (SARD) ligands and methods of use thereof Grant 11,230,531 - Narayanan , et al. January 25, 2	2022-01-25
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20210340122 - NARAYANAN; Ramesh ; et al.	2021-11-04
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20210253525 - NARAYANAN; Ramesh ; et al.	2021-08-19
Pharmaceutical Compositions For Treating Breast Cancers And Methods Of Uses Thereof App 20210228529 - STEINER; Mitchell S. ; et al.	2021-07-29
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20210196678 - NARAYANAN; Ramesh ; et al.	2021-07-01
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use App 20210161864 - NARAYANAN; Ramesh ; et al.	2021-06-03
Non-invasive Method Of Evaluating Breast Cancers For Selective Androgen Receptor Modulator (sarm) Therapy App 20210128513 - Steiner; Mitchell S. ; et al.	2021-05-06
Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs) Grant 10,987,334 - Narayanan , et al. April 27, 2	2021-04-27
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20210024458 - NARAYANAN; Ramesh ; et al.	2021-01-28
Selective androgen receptor degrader (SARD) ligands and methods of use thereof Grant 10,865,184 - Narayanan , et al. December 15, 2	2020-12-15
Non-invasive method of evaluating breast cancers for selective androgen receptor modulator (SARM) therapy Grant 10,849,873 - Steiner , et al. December 1, 2	2020-12-01
Selective androgen receptor degrader (SARD) ligands and methods of use thereof Grant 10,806,720 - Narayanan , et al. October 20, 2	2020-10-20
Selective androgen receptor degrader (SARD) ligands and methods of use thereof Grant 10,806,719 - Narayanan , et al. October 20, 2	2020-10-20
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20200299243 - NARAYANAN; Ramesh ; et al.	2020-09-24
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20200222365 - NARAYANAN; Ramesh ; et al.	2020-07-16
Selective androgen receptor modulator and methods of use thereof Grant 10,662,148 - Narayanan , et al.	2020-05-26
Selective androgen receptor degrader (SARD) ligands and methods of use thereof Grant 10,654,809 - Narayanan , et al.	2020-05-19
Selective androgen receptor degrader (SARD) ligands and methods of use thereof Grant 10,597,354 - Narayanan , et al.	2020-03-24
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20200039924 - NARAYANAN; Ramesh ; et al.	2020-02-06
Selective androgen receptor degrader (SARD) Ligands and methods of use thereof Grant 10,441,570 - Narayanan , et al. Oc	2019-10-15
Selective androgen receptor degrader (SARD) ligands and methods of use thereof Grant 10,314,797 - Narayanan , et al.	2019-06-11
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) Grant 10,314,807 - Dalton , et al.	2019-06-11
SARMs and method of use thereof Grant 10,300,037 - Dalton , et al.	2019-05-28
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20190144387 - NARAYANAN; Ramesh ; et al.	2019-05-16
Non-invasive Method Of Evaluating Breast Cancers For Selective Androgen Receptor Modulator (sarm) Therapy App 20190125716 - STEINER; Mitchell S. ; et al.	2019-05-02
Method Of Treating Er Mutant Expressing Breast Cancers With Selective Androgen Receptor Modulators (sarms) App 20190111010 - NARAYANAN; Ramesh ; et al.	2019-04-18
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) Grant 10,258,596 - Dalton , et al.	2019-04-16
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20190060280 - NARAYANAN; Ramesh ; et al.	2019-02-28
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20190040000 - Narayanan; Ramesh ; et al.	2019-02-07
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20190015387 - NARAYANAN; Ramesh ; et al.	2019-01-17
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20180360805 - NARAYANAN; Ramesh ; et al.	2018-12-20
METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs App 20180353460 - NARAYANAN; Ramesh ; et al.	2018-12-13
METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs App 20180325858 - Narayanan; Ramesh ; et al.	2018-11-15
Selective androgen receptor degrader (SARD) ligands and methods of use thereof Grant 10,093,613 - Narayanan , et al. October 9, 2	2018-10-09
Selective Androgen Receptor Modulator And Methods Of Use Thereof App 20180273470 - NARAYANAN; Ramesh ; et al.	2018-09-27
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20180273487 - NARAYANAN; Ramesh ; et al.	2018-09-27
Selective androgen receptor degrader (SARD) ligands and methods of use thereof Grant 10,035,763 - Narayanan , et al. July 31, 2	2018-07-31
Selective androgen receptor degrader (SARD) ligands and methods of use thereof Grant 10,017,471 - Narayanan , et al. July 10, 2	2018-07-10
SARMs and method of use thereof Grant 10,010,521 - Dalton , et al. July 3, 2	2018-07-03
METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs App 20180177755 - NARAYANAN; Ramesh ; et al.	2018-06-28
Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) Grant 9,969,683 - Dalton , et al. May 15, 2	2018-05-15
Sarms And Method Of Use Thereof App 20180116994 - DALTON; James T. ; et al.	2018-05-03
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20180118663 - NARAYANAN; Ramesh ; et al.	2018-05-03
Selective androgen receptor modulator and methods of use thereof Grant 9,884,038 - Dalton , et al. February 6, 2	2018-02-06
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20170368003 - NARAYANAN; Ramesh ; et al.	2017-12-28
SARMs and method of use thereof Grant 9,844,528 - Dalton , et al. December 19, 2	2017-12-19
Selective androgen receptor degrader (SARD) ligands and methods of use thereof Grant 9,834,507 - Narayanan , et al. December 5, 2	2017-12-05
Selective androgen receptor degrader (SARD) ligands and methods of use thereof Grant 9,814,698 - Narayanan , et al. November 14, 2	2017-11-14
Selective androgen receptor degrader (SARD) ligands and methods of use thereof Grant 9,815,776 - Narayanan , et al. November 14, 2	2017-11-14
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) Grant 9,744,149 - Dalton , et al. August 29, 2	2017-08-29
SARMs and method of use thereof Grant 9,730,908 - Dalton , et al. August 15, 2	2017-08-15
Method Of Treating Her2-positive Breast Cancers With Selective Androgen Receptor Modulators (sarms) App 20170209407 - Dalton; James T. ; et al.	2017-07-27
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20170166526 - Narayanan; Ramesh ; et al.	2017-06-15
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20170137374 - Narayanan; Ramesh ; et al.	2017-05-18
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) Grant 9,622,992 - Dalton , et al. April 18, 2	2017-04-18
Nuclear receptor binding agents Grant 9,623,021 - Narayanan , et al. April 18, 2	2017-04-18
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20170095446 - NARAYANAN; Ramesh ; et al.	2017-04-06
Nuclear receptor binding agents Grant 9,604,931 - Narayanan , et al. March 28, 2	2017-03-28
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) Grant 9,604,916 - Dalton , et al. March 28, 2	2017-03-28
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20170050921 - NARAYANAN; Ramesh ; et al.	2017-02-23
Selective Androgen Receptor Degrader (sard) Ligands And Methods Of Use Thereof App 20170029370 - Narayanan; Ramesh ; et al.	2017-02-02
Nuclear Receptor Binding Agents App 20170014401 - Dalton; James T. ; et al.	2017-01-19
Sarms And Method Of Use Thereof App 20170014370 - Dalton; James T. ; et al.	2017-01-19
Sarms And Method Of Use Thereof App 20170014371 - DALTON; James T. ; et al.	2017-01-19
Method Of Treating Her2-positive Breast Cancers With Selective Androgen Receptor Modulators (sarms) App 20170007567 - DALTON; James T. ; et al.	2017-01-12
Estrogen receptor ligands and methods of use thereof Grant 9,409,856 - Dalton , et al. August 9, 2	2016-08-09
Method Of Treating Androgen Receptor (ar) -positive Breast Cancers With Selective Androgen Receptor Modulator (sarms) App 20160128968 - DALTON; James T. ; et al.	2016-05-12
METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs App 20160106702 - NARAYANAN; Ramesh ; et al.	2016-04-21
Estrogen Receptor Ligands And Methods Of Use Thereof App 20160031797 - DALTON; James T. ; et al.	2016-02-04
Method Of Treating Androgen Receptor (ar) -positive Breast Cancers With Selective Androgen Receptor Modulator (sarms) App 20140350102 - Dalton; James T. ; et al.	2014-11-27
Method Of Treating Estrogen Receptor (er) -positive Breast Cancers With Selective Androgen Receptor Modulator (sarms) App 20140080905 - Dalton; James T. ; et al.	2014-03-20
Nuclear receptor binding agents Grant 8,637,706 - Dalton , et al. January 28, 2	2014-01-28
Method Of Treating Androgen Receptor (ar) -positive Breast Cancers With Selective Androgen Receptor Modulator (sarms) App 20140018433 - Dalton; James T. ; et al.	2014-01-16
Nuclear Receptor Binding Agents App 20130150403 - NARAYANAN; Ramesh ; et al.	2013-06-13
Aldo-keto Reductase Subfamily 1c3 (akr1c3) Inhibitors App 20130116277 - DALTON; James T. ; et al.	2013-05-09
Nuclear Receptor Binding Agents App 20120157539 - DALTON; James T. ; et al.	2012-06-21
Nuclear receptor binding agents Grant 8,158,828 - Dalton , et al. April 17, 2	2012-04-17
Nuclear Receptor Binding Agents App 20100267767 - NARAYANAN; Ramesh ; et al.	2010-10-21
Nuclear receptor binding agents App 20090062341 - Dalton; James T. ; et al.	2009-03-05
Nuclear receptor binding agents App 20070265296 - Dalton; James T. ; et al.	2007-11-15
Document processing system having integrated expert module Grant 5,225,978 - Petersen , et al. July 6, 1	1993-07-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.